NCT06115486
- Conditions
- Behavior, Breast Cancer, Breast Cancer Female, +16 more
- Locations
-
- Allegheny General Hospital Pittsburgh, Pennsylvania, United States
Clinical trial condition
Breast Carcinoma in Situ
Explore clinical trials studying Breast Carcinoma in Situ. Study availability and eligibility vary by location and protocol.
12 public trials
4 recruiting studies
Breast Carcinoma in Situ trial results
NCT02620852
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Cancer Screening, +14 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of California Irvine Irvine, California, United States
- University of California Los Angeles Los Angeles, California, United States
- University of California Davis Sacramento, California, United States
Recruiting
Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)
NCT06401304
- Conditions
- Anisomastia, Breast Asymmetry, Breast Cancer, +13 more
- Locations
-
- Westmead Breast Cancer Institute Sydney, Australia
- Uppsala University Hospital Uppsala, Sweden
- Royal Marsden Hospital London, United Kingdom
NCT04603209
- Conditions
- Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +10 more
- Locations
-
- John Wayne Cancer Institute, Providence Saint John's Health Center Santa Monica, California, United States
Not yet recruiting
The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCIS
NCT06217458
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Carcinoma in Situ, +18 more
- Locations
-
- Clinical Hospital Centre Rijeka Rijeka, Primorsko Goranska County, Croatia
Enrolling by invitation
Trastuzumab Plus Taxane Neoadjuvant Therapy for HER2-Positive Breast Ductal Carcinoma In Situ (DCIS) : A Phase II Study
NCT06843681
- Conditions
- Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +9 more
- Locations
-
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China
Active, not recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery
NCT03317405
- Conditions
- Adenocarcinoma, Breast Carcinoma In Situ, Breast Carcinoma in Situ, +24 more
- Locations
-
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Northwestern University Chicago, Illinois, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
NCT02954874
- Conditions
- Breast Carcinoma In Situ, Breast Carcinoma in Situ, Breast Diseases, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States
NCT05263362
- Conditions
- Breast Cancer, Breast Cancer Female, Breast Carcinoma, +16 more
- Locations
-
- Albert Schweitzer hospital Dordrecht, Netherlands
- Erasmus Medical Center Rotterdam, Netherlands
- Maasstad hospital Rotterdam, Netherlands
- Franciscus Gasthuis & Vlietland Schiedam, Netherlands
NCT06335108
- Conditions
- Breast Carcinoma, Breast Carcinoma In Situ, Breast Carcinoma in Situ, +10 more
- Locations
-
- University Women's Hospital Tübingen, Germany